ClinicalTrials HQ

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

Recruiting · NCT06228924 · Registry updated 2025-02-06
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCCardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, arrhythmogenic right ventricular cardiomyopathy, cardiomyopathy, cardiovascular disorder, congenital heart disease, heart disorder, heart failureRecruitingPhase 12025-02-06NCT06228924

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Tenaya Therapeutics4

7 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Brigham and Women's HospitalBostonUnited States511
Cleveland ClinicClevelandUnited States558
Johns Hopkins UniversityBaltimoreUnited States150
Mayo ClinicRochesterUnited States664
NYU Langone HealthNew YorkUnited States403
University of California San FranciscoSan FranciscoUnited States144
University of Colorado - Anschutz Medical CampusAuroraUnited States14